Sharing Progress in Cancer Care

Anrufen Wegbeschreibung Website

Sharing Progress in Cancer Care SPCC is a non-profit association, based in Switzerland, working in the field of cancer education.

Precision oncology is rapidly transforming the landscape of cancer treatment, yet ensuring equitable and sustainable pat...
06/10/2026

Precision oncology is rapidly transforming the landscape of cancer treatment, yet ensuring equitable and sustainable patient access remains one of healthcare’s most pressing challenges.

Bridging the gap between groundbreaking genomic testing and routine clinical delivery requires a coordinated approach across health technology assessment, policy frameworks, and streamlined care pathways.

To examine these critical issues, SPCC and All.Can International are pleased to announce our upcoming joint live webinar, "Data, policy & access – building a sustainable precision oncology ecosystem", taking place on Wednesday, 14 October 2026, from 18:00 to 19:00 CEST.

Chaired by Pietro Presti, this CME-accredited session brings together key experts to explore actionable solutions. Matt Hickey (The Health Value Alliance) will discuss data-driven value and policy frameworks for sustainable access, whilst Juliana Calheiros (Digestive Cancers Europe) will address the real-world accessibility pathways connecting diagnostic testing directly to treatment and patient care.

The presentations will conclude with a live Q&A session.

Participation is free of charge, but prior registration is mandatory.
👉 Secure your place on OncoCorner: https://www.oncocorner.net/index.php?p=events&id=A-536

This session is part of the SPCC Sustaining Corporate Programme 2026.
Sharing Progress in Cancer Care wishes to extend appreciation to its Sustaining Companies for providing unrestricted educational support to the following webinar. Companies have no control over the session content or speakers.

Did you recently explore OncoCorner?Our digital hub brings together curated content and forward-looking perspectives fro...
25/09/2026

Did you recently explore OncoCorner?
Our digital hub brings together curated content and forward-looking perspectives from across the global cancer care community.

A platform grounded in SPCC’s commitment to improving outcomes for every patient, everywhere.

👉🏼 https://www.oncocorner.net/ 👈🏼

Make sure to unlock everything this space has to offer, which is made possible thanks to the continuous commitment of the companies part of the Sustaining Corporate Programme. We would also like to acknowledge the unconditional support of Astrazeneca S.p.A.

Meet the multidisciplinary experts leading our upcoming discussion on integrative oncology and survival outcomes!On Tues...
22/09/2026

Meet the multidisciplinary experts leading our upcoming discussion on integrative oncology and survival outcomes!

On Tuesday 6 October 2026, from 18:00 to 19:00 CEST, SPCC will launch a new session of its Corporate Programme on Integrative Oncology: "Supportive care enhances patient survival".

Co-chaired by Matti Aapro and Karim Nagui, this live webinar brings together internationally recognised leaders to examine how personalized supportive care directly influences treatment efficacy and host biology. Julie Gralow will explore the evidence behind exercise as a core therapeutic intervention, whilst Prof. Andreas Charalambous will address how integrating structured symptom management directly improves survival outcomes.

The presentations will be followed by an interactive Q&A session, giving participants the opportunity to engage directly with the faculty.

Participation is free of charge, but prior registration is mandatory.
👉 Secure your place on OncoCorner: https://www.oncocorner.net/index.php?p=events&id=A-531

This session is part of the SPCC Sustaining Corporate Programme 2026.
Sharing Progress in Cancer Care wishes to extend appreciation to its Sustaining Companies for providing unrestricted educational support to the following webinar. Companies have no control over the session content or speakers.

Integrating biomarker-driven care into routine practice demands practical strategies for the entire multidisciplinary te...
18/09/2026

Integrating biomarker-driven care into routine practice demands practical strategies for the entire multidisciplinary team.

With just ten days to go, register now for the Definitive Trial Project online course, "Precision Oncology in HER2-Positive Breast Cancer: From Biomarkers to Personalised Care", broadcasting live on Monday, 28 September 2026, from 12:00 to 15:00 CEST.

Chaired by Matti Aapro and Seamus O’Reilly, this interactive three-hour session will examine how emerging evidence can directly inform everyday treatment pathways.

Our expert faculty, Paola Clauser, Marta González, Monika Gräser, Gaia Griguolo, Esther Sanfeliu, and Francesco Schettini, will address key clinical challenges including precision diagnostics, escalation and de-escalation strategies, and the integration of predictive tools such as HER2DX®.

An application for CME accreditation has been submitted to the Accreditation Council of Oncology in Europe (ACOE).

Participation is free of charge, but prior registration is mandatory.
👉 Secure your place on OncoCorner: https://www.oncocorner.net/index.php?p=events&id=C-55

Funded by the European Union – Horizon Europe Grant Agreement No. 101136953.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.
This work has also received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).

Meet the experts driving our upcoming discussion on the future of AI in cancer care! On Tuesday 29 September, from 18:00...
16/09/2026

Meet the experts driving our upcoming discussion on the future of AI in cancer care!

On Tuesday 29 September, from 18:00 to 19:00 CEST, SPCC will host a dedicated live webinar examining how artificial intelligence is moving from theoretical promise into clinical reality.

Led by discussant Pietro Presti, MBA, PhD, this interactive session brings together two leading specialists to unpack the clinical value of AI:

🩺 Aleksandra Filipovic MD Ph.D. (Imperial College London) will present the hallmarks of artificial intelligence contributions to precision oncology.

🩺 Rebecca Romanò (Fondazione IRCCS Istituto Nazionale dei Tumori) will explore current real-world applications alongside emerging future perspectives.

The presentations will culminate in a live, interactive Q&A session where attendees can join the discussion and put their questions directly to the experts.

Participation is free of charge, but prior registration is required.

👉 Register today to secure your place: https://www.oncocorner.net/index.php?p=events&id=A-533

This session is part of the SPCC Sustaining Corporate Programme 2026. This session is part of the SPCC Sustaining Corporate Programme 2026.
Sharing Progress in Cancer Care wishes to extend appreciation to its Sustaining Companies for providing unrestricted educational support to the following webinar. Companies have no control over the session content or speakers.

Growing clinical evidence confirms that supportive care plays a direct role in improving overall survival, shifting the ...
03/09/2026

Growing clinical evidence confirms that supportive care plays a direct role in improving overall survival, shifting the way we approach comprehensive cancer treatment.

Integrative oncology, combining standard therapeutic regimens with targeted exercise, nutrition, and symptom control, optimises treatment delivery and positively influences host biological factors.

To explore this clinical paradigm, SPCC is launching the live webinar: Supportive care enhances patient survival, scheduled for Tuesday 6 October 2026, at 18:00 CEST.

Co-chaired by Matti Aapro and Karim Nagui, this interactive hour features key presentations from global experts. Julie Gralow will examine the clinical impact of exercise in oncology pathways, whilst Prof. Andreas Charalambous will discuss how systematic symptom management directly translates into improved survival outcomes.

💬 A live Q&A session will follow the expert talks.
Participation is free of charge, but prior registration is mandatory.

👇🏼 Register on OncoCorner. 👇🏼
https://www.oncocorner.net/index.php?p=events&id=A-531

This session is part of the SPCC Sustaining Corporate Programme 2026.
Sharing Progress in Cancer Care wishes to extend appreciation to its Sustaining Companies for providing unrestricted educational support to the following webinar. Companies have no control over the session content or speakers.

How can we effectively translate emerging biomarker evidence into daily multidisciplinary decisions for breast cancer ca...
28/08/2026

How can we effectively translate emerging biomarker evidence into daily multidisciplinary decisions for breast cancer care?

We are delighted to announce the launch of the new online course for the Definitive Trial Project, "Precision Oncology in HER2-Positive Breast Cancer: From Biomarkers to Personalised Care", broadcasting live on 📆 Monday, 28 September 2026, from 12:00 to 15:00 CEST.

Chaired by Matti Aapro and Seamus O’Reilly, this interactive three-hour session gathers an outstanding international faculty, including Paola Clauser, Marta González, Monika Gräser, Gaia Griguolo, Esther Sanfeliu Torres, and Francesco Schettini.

Together, they will explore the full continuum of care, from precision imaging and diagnostic biomarkers to treatment escalation, de-escalation strategies, and the clinical integration of tools like HER2DX®.

Participation is free of charge, but registration is mandatory.
👉 Secure your place on OncoCorner: https://www.oncocorner.net/index.php?p=events&id=C-55

Funded by the European Union – Horizon Europe Grant Agreement No. 101136953.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.
This work has also received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).

Are you looking to bridge the gap between clinical evidence and real-world patient expectations in supportive cancer car...
06/08/2026

Are you looking to bridge the gap between clinical evidence and real-world patient expectations in supportive cancer care?

The on-demand recording of our recent symposium at the MASCC/ISOO 2026 Annual Meeting, "Improving outcomes in MEC: clinical evidence, trial insights and the patient perspective", is now available free of charge on OncoCorner.

Chaired by Matti Aapro and Florian Scotté, this session dives into the persistent challenges and unmet needs in managing moderate emetogenic chemotherapy (MEC). Featuring critical insights from Mario Di Palma on current treatment landscapes, Matti Aapro on trial data for risk assessment, and Eva Schumacher-Wulf on the patient voice, the discussion delivers essential guidance for healthcare professionals, researchers, and patient advocates alike.

👉 Watch the full session on-demand: https://www.oncocorner.net/index.php?p=events&id=A-535

Multinational Association of Supportive Care in Cancer - MASCC

OncoCorner is SPCC’s digital space where perspectives, insights, and forward-looking developments across the cancer care...
28/07/2026

OncoCorner is SPCC’s digital space where perspectives, insights, and forward-looking developments across the cancer care continuum come together.

A place shaped by our mission to connect stakeholders committed to meaningful innovation and to improving outcomes for every patient, everywhere.

It is made possible thanks to the continuous commitment of the companies part of the Sustaining Corporate Programme. We would also like to acknowledge the unconditional support of Astrazeneca S.p.A.

Explore more: www.oncocorner.net/

How can artificial intelligence move from a technological trend to an active driver of clinical decisions?Artificial int...
10/07/2026

How can artificial intelligence move from a technological trend to an active driver of clinical decisions?

Artificial intelligence is increasingly embedded across all stages of cancer care, offering transformative opportunities to enhance diagnostic accuracy, optimise workflows, and support therapeutic choices.

📆 To explore this evolution, join us on Tuesday 29 September 2026, from 18:00 to 19:00 CEST, for our live webinar "Explore how AI is reshaping oncology, from foundational concepts to future applications".

Led by Pietro Presti, the session features insights from Aleksandra Filipovic on the contributions of AI to precision oncology, and Rebecca Romanò on current applications and future perspectives. The presentations will be followed by an interactive Q&A session to address your questions.

Participation is free of charge, but registration is mandatory.
👉 Secure your place here: https://www.oncocorner.net/index.php?p=events&id=A-533

This session is part of the SPCC Sustaining Corporate Programme 2026.
Sharing Progress in Cancer Care wishes to extend appreciation to its Sustaining Companies for providing unrestricted educational support to the following webinar. Companies have no control over the session content or speakers.

Adresse

Via Vincenzo Vela 6
Bellinzona
6500

Benachrichtigungen

Erfahren Sie als Erste/r von Neuigkeiten und Aktionen: Wir schicken Ihnen eine E-Mail, wenn Sharing Progress in Cancer Care etwas veröffentlicht. Ihre E-Mail-Adresse wird für keinen anderen Zweck verwendet, und Sie können sich jederzeit abmelden.

Teilen